Від молока до медицини: 100 років безперервного вдосконалення фармацевтичної лактози

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…

The pharmaceutical company Darnitsa, a leading manufacturer of medicines in Ukraine, announced that it has entered into the London Chamber of Commerce and Industry (LCCI), which is an important step…